Evidence map›Paper›PMID 33349974›Full record

ArticleMagnetic resonance in medicine2020

Erratum to: Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients (Magn Reson Med. 2019; 81: 3358-3369).

Edzo M E Klawer, Petra J van Houdt, Frank F J Simonis, Cornelis A T van den Berg, Floris J Pos, Stijn W T P J Heijmink, Sofie Isebaert, Karin Haustermans, Uulke A van der Heide

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Magnetic resonance in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Edzo M E KlawerDepartment of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Petra J van HoudtDepartment of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Frank F J SimonisDepartment of Radiation Oncology, Imaging Division, University Medical Center, Utrecht, the Netherlands.
Cornelis A T van den BergDepartment of Radiation Oncology, Imaging Division, University Medical Center, Utrecht, the Netherlands.
Floris J PosDepartment of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Stijn W T P J HeijminkDepartment of Radiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sofie IsebaertDepartment of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Karin HaustermansDepartment of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Uulke A van der HeideDepartment of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-4146-6419

Funding

European Commission 600852European Commission FP7-ICT-2011-9
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33349974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.